1. Correlates of immunity in SARS-CoV-2 post-vaccine infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study
- Author
-
PMB, SOM, Emilie Goguet, Carol D. Weiss, Cara H. Olsen, John H. Powers III, Si'Ana A. Coggins, David R. Tribble, Julian Davies, William A. Meyer, Sara Ansari, Luca Illinik, Sabrina Lusvarghi, Margaret Sanchez Edwards, Belinda M. Jackson-Thompson, Monique Hollis-Perry, Simon Pollett, Gregory Wang, Yolanda Alcorta, Mimi A. Wong, David Saunders, Roshila Mohammed, Orlando Ortega, Edward Parmelee, Alyssa R. Lindrose, Hannah Haines-Hull, Matthew S. Moser, Emily C. Samuels, Marana S. Tso, Elizabeth Graydon, Allison M.W. Malloy, Kevin L. Schully, Timothy H. Burgess, Christopher C. Broder, Eric D. Laing, Edward Mitre, PMB, SOM, Emilie Goguet, and Carol D. Weiss, Cara H. Olsen, John H. Powers III, Si'Ana A. Coggins, David R. Tribble, Julian Davies, William A. Meyer, Sara Ansari, Luca Illinik, Sabrina Lusvarghi, Margaret Sanchez Edwards, Belinda M. Jackson-Thompson, Monique Hollis-Perry, Simon Pollett, Gregory Wang, Yolanda Alcorta, Mimi A. Wong, David Saunders, Roshila Mohammed, Orlando Ortega, Edward Parmelee, Alyssa R. Lindrose, Hannah Haines-Hull, Matthew S. Moser, Emily C. Samuels, Marana S. Tso, Elizabeth Graydon, Allison M.W. Malloy, Kevin L. Schully, Timothy H. Burgess, Christopher C. Broder, Eric D. Laing, Edward Mitre
- Abstract
Correlates of immunity in SARS-CoV-2 post-vaccine infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study Emilie Goguet1,2, Carol D. Weiss3, Cara H. Olsen4, John H. Powers III5, Si’Ana A. Coggins1,2, David R. Tribble6,Julian Davies2,6, William A. Meyer7, Sara Ansari7, Luca Illinik2,6, Sabrina Lusvarghi3, Margaret Sanchez Edwards2,6, Belinda M. Jackson-Thompson1,2, Monique Hollis-Perry8, Simon Pollett2,6, Gregory Wang8,9, Yolanda Alcorta8,9, Mimi A. Wong8,9, David Saunders10, Roshila Mohammed2,10, Orlando Ortega2,6, Edward Parmelee2,6, Alyssa R. Lindrose1,2, Hannah Haines-Hull1,2, Matthew S. Moser1,2, Emily C. Samuels1,2, Marana S. Tso1, 2 , Elizabeth Graydon1,2, Allison M.W. Malloy11, Kevin L. Schully12, Timothy H. Burgess6, Christopher C. Broder1, Eric D. Laing1, Edward Mitre1 1 Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA 2 Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA 3 Division of Viral Products, Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA 4 Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA 5 Clinical Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA 6 Infectious Diseases Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA 7Quest Diagnostics, Secaucus, NJ, USA 8 Clinical Trials Center, Infectious Diseases Directorate, Naval Medical Research Center, Silver Spring, MD, USA 9 General Dynamics Information Technology, Falls Church, VA, USA 10Translational Medicine Unit, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA 11 Department o, RITM0029809, We sought to determine pre-infection correlates of immunity against SARSCoV- 2 post-vaccine infections in a prospective cohort of healthcare workers.
- Published
- 2022